Compare UNF & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UNF | ADMA |
|---|---|---|
| Founded | 1936 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.6B |
| IPO Year | 1994 | 2012 |
| Metric | UNF | ADMA |
|---|---|---|
| Price | $255.52 | $9.31 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $228.00 | $32.00 |
| AVG Volume (30 Days) | 442.4K | ★ 9.1M |
| Earning Date | 04-01-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.57% | N/A |
| EPS Growth | ★ 2.70 | N/A |
| EPS | ★ 1.89 | 0.60 |
| Revenue | ★ $1,696,489,000.00 | $42,219,783.00 |
| Revenue This Year | $3.40 | $27.46 |
| Revenue Next Year | $3.54 | $22.11 |
| P/E Ratio | $135.55 | ★ $15.32 |
| Revenue Growth | 6.63 | ★ 43.85 |
| 52 Week Low | $147.66 | $7.21 |
| 52 Week High | $283.77 | $25.67 |
| Indicator | UNF | ADMA |
|---|---|---|
| Relative Strength Index (RSI) | 53.39 | 25.54 |
| Support Level | $166.39 | $7.21 |
| Resistance Level | $283.77 | $16.44 |
| Average True Range (ATR) | 5.66 | 1.10 |
| MACD | -2.66 | -0.33 |
| Stochastic Oscillator | 29.61 | 22.07 |
UniFirst Corp provides uniform and workwear programs, facility management, and safety supplies and services across North America. It designs, manufactures, rents, cleans, and sells uniforms and protective clothing, including flame-resistant and high-visibility garments. It also offers industrial wiping products, floor mats, cleaning supplies, first aid cabinets, and fire protection services such as inspection and maintenance. Serving various industries, the company provides customized uniforms and specialized cleaning for nuclear and cleanroom facilities. It operates through three segments: Uniform & Facility Service Solutions, First Aid & Safety Solutions, and Other, with the majority of revenue from Uniform & Facility Service Solutions.
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.